Eating tips to boost fertility revealed

Women watching their weight and closely following a Mediterranean-style diet that is high in vegetables, vegetable oils, fish and beans may boost their chance of becoming pregnant, according to dietitians.

Brooke Schantz, MS, RD, CSSD, LDN, LUHS, said that establishing a healthy eating pattern and weight is a good first step for women who are looking to conceive.

She said that not only will a healthy diet and lifestyle potentially help with fertility, but it also may influence foetal well-being and reduce the risk of complications during pregnancy.

Schantz said that reduced intake of foods with trans and saturated fats while increasing intake of monounsaturated fats, like avocados and olive oil could help women who are looking to conceive.

Another tip was lower intake of animal protein and adding more vegetable protein and fibre to their diet.

She also said that incorporating more vegetarian sources of iron like legumes, tofu, nuts, seeds and whole grains may help women in their endeavour.

Source: ANI news

 


Mothers in UK offered Euro 200 for breastfeeding

breastfeedingNew mothers are to be offered up to £200 in shopping vouchers to encourage them to breastfeed their babies.

The pilot scheme is being targeted at deprived areas of South Yorkshire and Derbyshire and funded through collaboration between government and the medical research sector.

A third area is expected soon with the plan to trial it on 130 women who have babies from now until March.

If successful, a nationwide pilot could be rolled out in England next year.

The use of financial incentives is not new in the NHS.

It has been tried before to encourage people to quit smoking as well as lose weight.

Culture

But this is the first time it has been tried on such a scale for breastfeeding.

breastfeeding1

Under the scheme mothers from specific parts of Sheffield and Chesterfield will be offered the vouchers, which they can then use in supermarkets and high street shops.

The areas have been chosen because they have such low breastfeeding rates. On average just one in four mothers are breastfeeding by the six- to eight-week mark compared with a national average of 55%.

To qualify for the full £200 of rewards, the women will have to breastfeed until six months.

However, it will be frontloaded – enabling those taking part to get £120 for breastfeeding for the first six weeks.

Midwives and health visitors will be asked to verify whether the women are breastfeeding.

The team behind the project said breastfeeding was a cause of health inequalities, pointing to research that showed it helped prevent health problems such as upset stomachs and chest infections as well as leading to better educational attainment.Breastfeeding expert Geraldine Miskin Mums need to have practical advice

Dr Clare Relton, the Sheffield University expert leading the project, said she hoped the financial incentives would create a culture where breastfeeding was seen as the norm.

“It is a way of acknowledging both the value of breastfeeding to babies, mothers and society,” she added.

But Janet Fyle, of the Royal College of Midwives, questioned the initiative: “The motive for breastfeeding cannot be rooted by offering financial reward. It has to be something that a mother wants to do in the interest of the health and well-being of her child.”

She said the answer lay in making sure there was enough staff available to provide comprehensive support to new mothers after birth.

Source: BBC


How diabetic women`s pregnancy chances can be boosted

Watching what you eat, exercising properly and ensuring adequate nutrition with a vitamin supplement which has adequate amounts of folic acid may improve chances of conception in diabetic women.

Women with diabetes face a special challenge-getting and then staying pregnant. Poor glucose control may create an environment where the high sugars prevent both conceiving as well as maintaining the pregnancy, Diabetic Living India reported.

Women who develop diabetes can be prone to developing other disorders such as thyroid disease or autoimmune premature ovarian failure.

Miscarriage rates among women with poorly controlled diabetes can be as high as 30 to 60 percent during that crucial first trimester of pregnancy.

The risk of birth defects is also high, and also stems from uncontrolled blood sugar levels around the time of conception.

A baby’s brain, heart, kidneys and lungs form during the first eight weeks of pregnancy, therefore high blood glucose levels are especially harmful during this early stage.

The main diabetes complication, including gestational diabetes, related to pregnancy is macrosomia – or a big baby (higher than the 90th percentile in birth weight).

Women with Type 1 diabetes will require insulin before, during and after their pregnancy.

However, if a woman has type 2 diabetes then she will require oral medications with or without insulin to achieve appropriate control of your diabetes.

In order to enhance chances of delivering a healthy baby, diabetic women should work with health care team to get their blood glucose under control before getting pregnant.

Source: Smas Hits


Hunt for Environmental links to breast cancer

A decade-long research effort to uncover the environmental causes of breast cancer by studying both lab animals and a group of healthy US girls has turned up some surprises, according to AFP

At the center of the investigation are 1,200 schoolgirls who do not have breast cancer, but who have already given scientists important new clues about the possible origins of the disease.

Some risk factors are well understood, including early puberty, later age of childbearing, late onset of menopause, estrogen replacement therapy, drinking alcohol and exposure to radiation, AFP reports.

Advances have also been made in identifying risky gene mutations, but these cases make up a small minority.

“Most of breast cancer, particularly in younger women, does not come from family histories,” said Leslie Reinlib, a program director at the National Institute of Environmental Health Sciences.

“We have still got 80 percent that has got to be environmental,” said Reinlib, who is part of the Breast Cancer and the Environment Research Program (BCERP) program that has received some $70 million in funds from the US government since 2003.

Some of its researchers track what is happening in the human population, while others study how carcinogens, pollutants and diet affect the development of the mammary glands and breast tumors in lab mice.

The program’s primary focus is on puberty because its early onset “is probably one of the best predictors of breast cancer in women,” Reinlib said.

Puberty is a time of rapid growth of the breast tissue. Research on survivors of the Hiroshima atomic bombings in Japan has shown that those exposed in puberty had a higher likelihood of developing breast cancer in adulthood.

The 1,200 US girls enrolled in the study at sites in New York City, northern California and the greater Cincinnati, Ohio, area beginning in 2004, when they were between the ages of six and eight.

The aim was to measure the girls’ chemical exposures through blood and urine tests, and to learn how environmental exposures affected the onset of puberty and perhaps breast cancer risk later in life.

Researchers quickly discovered that their effort to reach girls before puberty had not been entirely successful.

“By age eight, 40 percent were already in puberty,” said Reinlib. “That was a surprising bit of information.”

Further research has shown that the girls appear to be entering puberty six to eight months earlier than their peers did in the 1990s.

A study published last week in the journal Pediatrics on this cohort of girls found that obesity was acting as a primary driver of earlier breast development.

Other studies on the girls have focused on chemicals that are known as endocrine disruptors because they are believed to cause either earlier or later breast development.

Initial results showed “for the first time that phthalates, BPA, pesticides are in all the girls they looked at,” said Reinlib.

Researchers were taken aback by the pervasiveness of the exposures, but also by the data which appeared to show some plastic chemicals might not be as influential on breast development as some have feared.

“They didn’t find much of an association between puberty and phthalates, which are these chemicals that leach out of plastic bottles and Tupperware,” Reinlib said.

Another major finding regarded blood chemicals from two nearby groups in Ohio and Kentucky, both drinking water that was apparently contaminated by industrial waste.

Girls in northern Kentucky had blood levels of an industrial chemical — perfluorooctanoic acid (PFOA or C-8) found in Teflon non-stick coating for pans — three times as high as those who drank water from the Ohio River near Cincinnati, where water was filtered with state-of-the-art technology.

“Northern Kentucky did not have granular activated carbon filtration” in their water supply said researcher Susan Pinney, a professor at the University of Cincinnati School of Medicine.

“In 2012 they put it in after they learned of our preliminary results.” Families were also notified of their daughters’ blood levels, she said.

The chemicals can linger in the body for years. Researchers were dismayed to learn that the longer the girls spent breastfeeding as infants — typically touted for its health benefits — the higher their PFOA levels compared to girls who were fed formula.

What cannot be studied in the girls is tried on lab mice, who in one experiment are being fed high-fat diets and exposed to a potent carcinogen to see how the two interact.

Mammary tumors develop much faster in the high-fat diet group, said scientist Richard Schwartz of the department of microbiology and molecular genetics at Michigan State University.

Fat mice have more blood supply in the mammary glands, higher inflammation levels and display changes in the immune system.

Follow-up studies suggest that cancer risk stays high even if mice are fed high-fat diets in puberty and switched to low-fat diets in adulthood, he told AFP.

“The damage is already done,” he said. “Does this mean that humans are at risk the same way? We don’t know that with certainty.”

But the findings do reinforce the advice that people often hear regarding how to maintain good health — avoid fatty foods, maintain a normal weight and reduce chemical exposures wherever possible, experts say.

“It can’t hurt, and it can only help,” said Schwartz.

Breast cancer is the most common cancer in women globally and took 508,000 lives in 2011, according to the World Health Organization.

Source: News OK


Women ‘more prone to breathlessness’

Women’s lung muscles have to work harder than men’s, making breathlessness more common after exercise, say scientists in Canada.

Their study in the journal Experimental Physiology examined the activity of the diaphragm – the muscle that drives lung function.

It had to work harder in women to compensate for smaller lungs, the research showed.

The research was conducted at McGill University.

Even with a man and a woman of equal size, the woman’s lungs are smaller and their airways narrower.

Breathlessness can occur after tough physical exercise or be a symptom of some illnesses such as bronchitis.

“In both health and diseases, women are more likely to show signs of breathlessness after physical activity than men,” said lead researcher Dr Dennis Jensen.

The study compared 25 men and 25 women between the ages of 20 and 40, exercising on a bicycle.

How deep and how fast they breathed at different levels of exercise were recorded. They also recorded the “drive to breathe”, the electrical signals sent to the diaphragm to control its movement.

Dr Jensen told the BBC: “Women have biologically smaller lungs and they have to activate respiratory muscles more to move a given amount of air.”

He said it was an “important insight into why women with emphysema and heart failure have worse breathing symptoms than men”.

Further studies will investigate the impact of obesity on breathlessness.

Source: Medical web times

ZMW5NPU6YKM8


Sanitary napkin may soon be available for Rs 2.50 apiece

A teacher-student duo of the Institute of Technology and Management (ITM) here has designed a machine that will be able to provide a biodegradable sanitary napkin for just Rs 2.50 apiece.

Assistant professor Ashwini Sharma, along with his student Surbhit Arora, used wood pulp to produce the napkin, which is both biodegradable and cost-effective.

“A majority of the rural and poor urban women in India use pieces of cloth and other unhygienic things during menstruation, as they cannot buy sanitary napkins which are expensive. We hope the machine will be helpful to them,” said Sharma.

The machine can make the napkin in a three-step process that involves pressing, sealing and cutting.

All these three steps occur in one cycle, in which four napkins are produced in one go.

“The machine is semi-automatic and uses only a small amount of power, so it can be used to run small and medium enterprises. This way, we also hope to generate employment for women in rural areas,” Sharma said.

National Institute of Design, Ahmedabad, under a scheme titled “Design Clinic Scheme” of medium and small enterprises, funded this project with a contribution of Rs 1.5 lakh.

“The project has been recently awarded the first prize for most innovative work at the national ‘Rural Entrepreneurship’ seminar in Jaipur. We promote innovation in our students in a big way, and we are happy that they have turned out to be social innovators,” said Prem Vrat, vice chancellor, ITM. [IANS]

Source: India medical times

 

 


Robot Detects Breast Cancer With Space-Grade Tech

The same technology designed for huge robotic arms that help astronauts in space is being brought back to Earth to do some heavy lifting in cancer treatment — in the form of a surgical robot. Its inventors say the robot could take breast biopsies with remarkable precision and consistency.

 The new machine is called IGAR, which is short for Image-Guided Autonomous Robot. NASA officials say it descends from a long line of robotic arms built for the Canadian Space Agency, such as Canadarm, which helped build the space station, service satellites and sometimes gave astronauts a lift during spacewalks, and Dextre, a maintenance robot on the space station. (This specific tech was developed by the British Columbia-based aerospace and communications firm MacDonald, Dettwiler and Associates Ltd.)

IGAR works in combination with a magnetic resonance imaging (MRI) scanner that can help doctors see potentially harmful mass in the breast. Currently, MRI is used to examine areas of the breast found on mammograms to be suspicious. With special software, a radiologist could tell IGAR which area to target with a needle-based biopsy device, or similar tissue-removing tool. [6 Foods That May Affect Breast Cancer Risk]

The space-inspired robot works with enough precision to insert the needle within about 0.3 inches (8 millimeters), of the suspicious lesion with a high degree of accuracy, said Dr. Mehran Anvari, chief executive officer and scientific director at Canada’s Centre for Surgical Invention and Innovation.

Anvari said IGAR will improve sampling, reduce the pain of the procedure, save time and, as a result, save money.

“It also will allow all radiologists to perform this procedure equally well, regardless of the number of cases per year and move the site of treatment from operation room to radiology suite for a significant number of patients,” Anvari explained in a statement from NASA.

Dr. Nathalie Duchesne, a breast radiologist at the Hospital Saint-Sacrement in Quebec City, will be performing the first of three clinical trials with IGAR. She, too, said she believes the surgical robot will make breast biopsies more consistent across different doctors, patients and types of lesions.

I’ve been teaching MRI-guided breast biopsy for years and there are many steps in the procedure that are operator-dependent,” Duchesne said in a statement. “These steps may prevent good sampling of the lesions if it’s not done properly. I believe IGAR will take care of this. It will subsequently decrease the time of the exam, ensure good sampling and increase patient’s comfort during the exam.”

NASA officials say IGAR could also be used to assist doctors in lumpectomies, a surgery that removes only the tumor and part of the surrounding breast tissues, as opposed to a mastectomy, in which the breast is removed. Some tumors might require a lumpectomy because they cannot be detected with ultrasound and X-ray mammography. Researchers say IGAR could be used deploy a tiny radioactive seed near the area of interest during a biopsy, which could later located with a detector, allowing the doctor to identify and remove the lesion.

The National Cancer Institute estimates that 232,340 American women and 2,240 men will be diagnosed with breast cancer in 2013, and that about 39,620 women and 410 men will die of the disease this year.

 

Source: Yahoo News


Cervical Cancer vaccine may miss mark for some black women

A black female’s genetic make-up may reduce the effectiveness of the human papillomavirus (HPV) vaccine in curbing rates of cervical cancer among that population, according to preliminary findings by researchers at Duke University School of Medicine and the University of North Carolina at Chapel Hill Epidemiology Department.

Cautioning that more research is needed before these early findings can be fully confirmed—HPV researchers elsewhere say it’s not been proven that other regions are witnessing the same patterns as those shown in this new study—the North Carolina research team investigated the potential interplay between the vaccine and different types of HPV diagnosed among the 572 Durham County, N.C. women who enrolled in the study.

“It was a single population from a single clinic. All of these women came a small geographic area, and we know that women tend to have sex partners in the area where they live,” Dr. Rebecca Perkins, a Boston University researcher of HPV in poor and under-served communities and gynecologist told the Grio. “It’s hard to [apply] take this to any other states or, for that matter, to a health center outside of Duke.”

Of the 572 women, ages 18 and older, 280 of them were black and 292 were non-Hispanic whites.

In reviewing cervical pap smears taken since 2010, more than half of the women had changes associated with developing cervical cancer — 239 early-stage and 88 in the advanced stage. And many of the women — 73 percent — were infected with more than one type of HPV. There are 40 subtypes in total.

The HPV vaccine prevents infection from subtypes 16 and 18. Combined, those two account for 70 percent of cervical cancers, these researchers wrote.

In the study out today, the white women with early and advanced pre-cancerous abnormalities tested positive for the HPV 16 and HPV 18 subtypes. But in black women, neither HPV 16 nor HPV 18 was commonly found.

Instead, the most commonly detected subtypes during the early precancerous stage were HPV subtypes 33, 35, 58 and 68. HPV subtypes 31, 35, 45, 56, 58, 66 and 68 were the most commonly detected in black women with advanced-stage pre-cancerous abnormalities.

“Compared with white women, we saw that African-American women had about half as many infections with HPV 16 and 18, the subtypes that are covered by HPV vaccines,” said Adriana Vidal, Ph.D., an assistant professor of obstetrics and gynecology at Duke and the study’s lead investigator, according to a press release. “Since African-American women don’t seem to be getting the same subtypes of HPV with the same frequency, the vaccines aren’t helping all women equally.”

This study has not been approved for publication in a medical journal, through the authors has applied to have their work published, Duke Medical Center spokeswoman Rachel Harrison told the Grio via email.

The research team is slated to present its findings during the American Association for Cancer Research’s 12th annual International Conference on Frontiers in Cancer Prevention Research, which opens Monday in National Harbor, Md.

Morehouse School of Medicine’s Dr. Hedwige DiDi Saint-Louis said she hopes these preliminary findings lead no one to reflexively believe the vaccine is either ineffective or unnecessary. She will continue to encourage her patients to get vaccinated, she said.

In 2006, the U.S. Food and Drug Administration approved the HPV vaccine for prevention of cervical cancer, a disease which kills a greater percentage of black women than white women. Sold under the brand names of Gardasil or Cervarix, the drug has been a debate for many, largely because it’s recommended for boys and girls to begin getting the series of three vaccination shots starting when they are about 11 or 12 years old.

One U.S. Centers for Disease Control and Prevention study concluded that the vaccine had cut in half the rate of sexually transmitted disease infections in teen girls.

Although a new HPV vaccine targeting HPV subtypes 16, 18 and seven other types is currently being tested in clinical trials, the Duke and University of North Carolina researchers noted that, even if approved for use, it may not address the challenges detailed in their research.

Similarly, Saint-Louis added that this study spotlights the lingering question of whether pharmaceutical firms, among others, are doing enough to ensure that their clinical trials include all racial and ethnic groups. Coupled with that is a lingering reluctance of many non-whites to sign up for trials that do exist.

“With most of these clinical trials, there’s an issue with recruiting African-Americans and other minority populations,” Saint-Louis said. “ … Always, we need to look at genetic differences in disease and treatment. The goal in clinical trials should be to get as wide a circle of participants as possible so that the trials represent the population at large. Then, you can confidently generalize about what the findings truly mean.”

Taking race-based genetics into account should be a front-end priority for drug-makers aiming to make effective medicines, Saint-Louis said. “If it isn’t, that greatly increases the likelihood that [pharmacology] is going to miss something that makes a difference for minority groups.”

Patricio Meneses, an epidemiologist and HPV researcher at Fordham University in New York City, said drug-makers might be better advised—and the public better served—by developing a more powerful “second-generation vaccine that actually attacks the biology of virus … after it gets inside the body’s cells.”

The current vaccines don’t go that far, he added. They work by keep the many subtypes of viruses from attaching to the outside of cells.

Source: http://on.thegrio.com/1avcwLs


Women’s Breasts Age Way Faster Than The Rest Of Their Bodies

A new technique for identifying the precise biological age of human tissue reveals that not all tissues grow old at the same rate.

A new technique for identifying the precise biological age of human tissue reveals that not all tissues grow old at the same rate. Not all parts of the body age alike, according to Steve Horvath, a geneticist at UCLA’s medical school. Horvath developed a way to determine the biological age of different tissues in the body by looking at DNA methylation, a chemical alteration of genes that has been suggested by previous studies to be a potential biomarker for a cell’s age.

Horvath looked at 8,000 healthy samples of 51 different types of cells and tissues and 6,000 cancerous samples to examine how the aging process affects DNA methylation levels. For the most part, his method accurately tied the biological age (the age predicted from the person’s DNA) to the chronological age of the donor.

Except that some tissues seemed to age far faster than others. “Healthy breast tissue is about two to three years older than the rest of woman’s body ” according to Horvath. Cancerous cells aged even more rapidly than that. Tumors appeared accelerate the tissue aging process by 36 years, and healthy breast tissue near breast tumors were an average of 12 years older than tissue elsewhere in the body. In contrast, transforming adult human cells into pluripotent stem cells, which reprograms them to act like embryonic stem cells, effectively “resets the cells’ clock to zero,” Horvath says.

The study is online in Genome Biology.

Source:


Polycystic Ovarian Syndrome; the new lifestyle disease

Troubled by facial hair, acne and irregular menstrual periods? Chances are you could be suffering from Polycystic Ovarian Syndrome (PCOS), a largely lifestyle-related disease in women of reproductive age, which is seeing a rise in India, especially among young girls.

Experts said while the exact cause of the condition is not known – for long it was considered a genetic disease – the problem largely affects the ovaries, the organs responsible for the production of eggs and female hormones. The condition runs in families.

“The incidence of women suffering from PCOS has doubled as it is difficult to diagnose-being a spectrum of diseases without having any one particular symptom,” Mala Srivastava, senior consultant at the obstetrics and gynaecology department of Sir Gangaram hospital, told IANS.

Doctors said that approximately 30-40 percent of teenagers coming to OPDs suffer from PCOS, which often affects younger women.

While the major cause for worry in women suffering from PCOS is infertility, it can also become life-threatening as it leads to an increase in incidence of obesity·

Around 40-60 percent of women with PCOS suffer from obesity, which in turn leads to diabetes, uterine cancer and high cholesterol.

Across the globe, 4-11 percent of the female population suffers from PCOS. While the incidence of PCOS is less among rural women, roughly 30 percent of the urban women population suffers from it.

It is a common endocrine disorder where there is an imbalance in the hormones produced in a woman’s body.

Pointing out obesity as being a major factor for PCOS, Srivastava said obesity leads to hormonal changes, which are responsible for PCOS.

According to her, certain women are insulin resistant, which leads to obesity in them and in turn results in hormonal imbalances and develops into PCOS.

Listing PCOS as the most common reproductive endocrinological disorder in women, Anita Talwar, senior consultant at the obstetrics and gynecology department of Max hospital, said it can even occur in girls as young as 11 years. The disorder manifests in 11.2 percent of women in their reproductive years with 50 percent comprising adolescent girls.

“We are seeing this problem among young girls, which is a worrying factor,” she said.

A study published last year in the American Journal of Clinical Nutrition examined the effects of a low glycemic index diet compared with a conventional low-fat, high-fibre diet on women with PCOS.

They found that women who followed a low glycemic index diet-a weight loss diet based on controlling blood sugar-had better insulin sensitivity and more menstrual regularity.

Treatment of PCOS depends partially on the woman’s stage of life.

For younger women who desire birth control, the birth control pill, especially those with low androgenic (male hormone-like) side effects, can revert the PCOS effect by leading to regular periods and prevent the risk of uterine cancer.

Another option is intermittent therapy with the hormone progesterone. Progesterone therapy induces menstrual periods and reduces the risk of uterine cancer, but does not provide contraceptive protection.

Srivastava said the need of the hour is to create more awareness about the problem among people, especially women.

Source: